Healthy high growth potential

Results

1485

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1485 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
SCHNEIDER
₹1,335.302.6%66.8%₹319.3b₹1,230.00150.234.0%n/aCapital Goods
501423
₹2,849.804.3%72.1%₹131.0b₹3,517.6777.133.7%0.1%Capital Goods
APOLLO
₹384.40-9.9%95.4%₹144.5b₹382.50128.041.3%0.06%Capital Goods
543273
₹2,240.509.0%166.8%₹54.8b₹2,500.0069.553.9%n/aTransportation
EIEL
₹218.5512.2%-7.2%₹38.4b₹346.0021.037.8%n/aCapital Goods
SAATVIKGL
₹475.35-0.3%n/a₹60.4b₹520.0016.948.8%n/aSemiconductors
VIKRAMSOLR
₹185.28-11.8%n/a₹67.1b₹246.6014.330.0%n/aSemiconductors
MIDWESTLTD
₹1,289.80-0.7%n/a₹46.6b₹1,500.0044.559.3%n/aMaterials
MONOLITH
₹750.859.1%185.8%₹16.3b₹960.0070.937.2%n/aMaterials
KEBNI B
SEK 1.23-3.0%-41.3%SEK 337.1mSEK 1.603.082.7%n/aTech
MDGL
US$513.791.6%71.5%US$11.8bUS$678.7110.559.2%n/aPharmaceuticals & Biotech
FWRY
ج.م18.70-1.1%47.8%ج.م63.7bج.م21.2423.928.7%n/aDiversified Financials
AXSM
US$237.33-5.3%131.4%US$12.2bUS$276.4717.257.4%n/aPharmaceuticals & Biotech
AGP
€7.031.9%-8.7%€128.2m€8.5725.837.8%n/aCapital Goods
CDR
zł223.400.2%-18.9%zł22.3bzł235.3843.227.1%0.4%Media
RHM
€946.80-19.7%-49.2%€43.9b€1,798.6042.030.6%1.2%Capital Goods
LITE
US$861.971.4%810.1%US$65.5bUS$1,111.29152.879.1%n/aTech
CRDO
US$268.03-1.4%182.0%US$50.2bUS$269.81105.827.5%n/aSemiconductors
MOD
US$283.67-4.6%178.8%US$14.6bUS$340.86123.349.3%n/aCapital Goods
NVDA
US$195.74-7.1%26.3%US$4.8tUS$298.9329.721.8%0.5%Semiconductors
2455
NT$348.00-16.3%167.7%NT$71.8bNT$398.50109.945.2%0.8%Semiconductors
4417
JP¥3,300.001.4%2.0%JP¥49.6bJP¥4,500.0033.424.1%1.0%Software
9218
JP¥704.001.0%6.2%JP¥7.4bn/a31.128.9%1.4%Healthcare
7769
NT$6,450.00-7.5%367.4%NT$1.2tNT$9,322.7180.543.7%1.0%Semiconductors
Page 1 of 42